sever
acut
respiratori
syndrom
sar
acut
infecti
diseas
signific
morbid
mortal
wang
chang
intens
cooper
worldwid
effort
led
identif
etiolog
agent
novel
sar
coronaviru
sarscov
guan
et
al
peiri
et
al
rota
et
al
subsequ
complet
sequenc
viral
genom
sarscov
belong
famili
larg
posit
singlestrand
rna
virus
sarscov
genom
kb
length
encod
put
open
read
frame
gener
potenti
protein
function
mani
known
marra
et
al
sequenc
comparison
known
coronavirus
reveal
similar
organ
sarscov
gene
typic
coronavirus
chen
et
al
coronavirus
known
caus
common
cold
human
infect
lead
lower
respiratori
tract
diseas
livestock
poultri
howev
sarscov
infect
result
sever
even
fatal
lung
diseas
human
week
onset
diseas
major
patient
recov
onethird
patient
develop
sever
symptom
mani
patient
latter
group
deterior
acut
respiratori
distress
syndrom
ard
high
mortal
convalesc
patient
gradual
shed
viru
process
may
take
long
time
howev
chronic
infect
sarscov
document
human
viru
found
respiratori
tract
secret
lung
tissu
serum
stool
tse
et
al
accord
data
autopsi
fatal
case
major
patholog
characterist
sar
patient
diffus
alveolar
damag
dad
chan
et
al
mechan
dad
believ
endotheli
alveolar
epitheli
injuri
due
direct
viral
effect
indirect
factor
nichol
et
al
earli
phase
sar
develop
day
lung
demonstr
featur
dad
includ
extens
edema
hyalin
membran
format
fluid
cellular
exud
collaps
alveoli
desquam
alveolar
epitheli
cell
time
fibrou
tissu
could
detect
alveolar
space
phase
refer
acut
stage
medium
phase
sar
develop
day
lung
display
fibrou
organ
includ
interstiti
airspac
fibrosi
repar
fibroblast
prolifer
type
ii
pneumocyt
hyperplasia
fibrou
organ
becom
extens
time
phase
refer
prolif
organ
stage
late
phase
sar
week
refer
fibrot
stage
lung
exhibit
dens
septal
alveolar
fibrosi
time
durat
count
onset
symptom
patholog
process
alway
evolv
three
stage
may
ceas
recov
phase
chan
et
al
cheung
et
al
gu
korteweg
guo
et
al
ketai
et
al
ng
et
al
nichol
et
al
tse
et
al
extent
lung
fibrosi
posit
correl
durat
sar
diseas
clinic
data
show
fibrou
organ
common
patient
late
phase
patient
earli
medium
phase
contrast
dad
like
happen
patient
earli
medium
phase
patient
late
phase
thu
lung
fibrosi
also
display
without
dad
hwang
et
al
importantli
lung
fibrosi
even
observ
sar
patient
recov
discharg
hospit
furthermor
preval
rate
lung
fibrosi
cure
sar
patient
month
discharg
tradit
therapi
lung
fibrosi
glucocorticoid
hormon
treatment
effect
sarsinduc
lung
fibrosi
regardless
dosag
method
length
drug
usag
interestingli
individu
lung
fibrosi
show
spontan
recoveri
xie
et
al
lung
fibrosi
patholog
consequ
acut
chronic
interstiti
lung
diseas
lung
fibrosi
character
fail
alveolar
reepitheli
fibroblast
persist
excess
deposit
collagen
extracellular
matrix
ecm
compon
well
destruct
normal
lung
architectur
sime
oreilli
progress
lung
fibrosi
result
widen
interstiti
matrix
eventu
compress
destruct
normal
lung
parenchyma
result
damag
capillari
lead
ventilatori
insuffici
razzaqu
taguchi
etiolog
lung
fibrosi
uncertain
smoke
viral
infect
drug
exposur
genet
predisposit
may
contribut
fibrot
process
chronic
inflamm
regard
main
reason
lung
fibrosi
result
epitheli
injuri
fibroblast
activ
howev
recent
studi
suggest
alveolar
epitheli
injuri
format
activ
myofibroblast
foci
main
reason
lung
fibrot
process
chapman
gharaeekermani
et
al
kalluri
neilson
razzaqu
taguchi
scotton
chamber
damag
take
place
lung
tissu
set
growth
factor
cytokin
includ
monocyt
chemoattract
transform
growth
tumor
necrosi
overexpress
releas
cell
type
ii
alveolar
epitheli
cell
one
major
sourc
fibrogen
factor
factor
turn
stimul
hyperprolifer
type
ii
alveolar
epitheli
cell
recruit
fibroblast
fibrot
loci
induc
transdifferentiationactiv
fibroblast
myofibroblast
myofibroblast
respons
excess
accumul
ecm
basement
membran
interstiti
tissu
final
lead
loss
alveolar
function
especi
ga
exchang
alveoli
capillari
razzaqu
taguchi
excess
accumul
ecm
may
result
increas
synthesi
decreas
degrad
ecm
express
deposit
collagen
major
event
ecm
accumul
variou
type
collagen
type
type
iii
type
vi
found
fibrot
lesion
lung
mani
factor
involv
ecm
degrad
amongst
plasminogen
activatorplasmin
system
play
import
role
activ
plasminogen
regul
physiolog
inhibitor
plasminogen
activ
inhibitor
fibrot
lung
patient
express
increas
delet
gene
reduc
suscept
mous
lung
fibrosi
induc
variou
stimuli
wherea
protein
overexpress
enhanc
indic
critic
develop
lung
fibrosi
izuhara
et
al
addit
plasminogen
proteolyt
enzym
includ
matrix
metalloproteinas
mmp
disintegrin
metalloproteinas
domain
adam
also
contribut
ecm
degrad
tissu
inhibitor
metalloproteinas
timp
acceler
emc
deposit
neutral
mmp
activ
gill
park
fibrot
lung
patient
wider
distribut
timp
compar
mmp
describ
suggest
lung
fibrosi
total
ecm
degrad
reduc
gill
park
izuhara
et
al
liu
razzaqu
taguchi
secret
cytokin
belong
superfamili
structurerel
growth
factor
includ
activin
bone
morphogenet
protein
bmp
other
signal
initi
via
bind
transmembran
receptor
heldin
et
al
hu
et
al
massagu
chen
shi
massagu
ligand
bind
result
format
heterocomplex
type
type
ii
receptor
type
ii
receptor
phosphoryl
activ
type
receptor
activ
type
receptor
phoshoryl
downstream
signal
mediat
rsmad
protein
form
heteromer
complex
common
accumul
nucleu
orchestr
express
target
gene
collabor
dnabind
factor
transcript
cofactor
addit
canon
smad
pathway
report
activ
mitogenactiv
protein
kinas
erk
jnk
kinas
akt
kinas
pak
other
derynck
akhurst
moustaka
heldin
superfamili
member
play
multifunct
regulatori
role
cell
growth
differenti
death
migrat
matrix
remodel
derynck
miyazono
hu
et
al
massagu
chen
dysregul
signal
associ
varieti
human
diseas
cancer
tissu
fibrosi
cardiovascular
disord
derynck
miyazono
massagu
chen
ten
dijk
arthur
transgen
studi
anim
model
reveal
import
activ
process
lung
fibrosi
use
replicationdefici
adenoviru
vector
transfer
cdna
rat
lung
effect
protein
respiratori
tract
directli
test
transient
overexpress
activ
result
sever
interstiti
pleural
fibrosi
sime
et
al
solubl
type
ii
receptor
consist
extracellular
domain
bind
function
antagonist
shown
inhibit
lung
fibrosi
anim
model
lee
et
al
activ
hallmark
event
lung
fibrot
process
fibrot
lung
tissu
level
mrna
well
protein
increas
rube
et
al
stimul
product
ecm
protein
enhanc
secret
proteas
inhibitor
timp
reduc
secret
proteas
thu
lead
deposit
ecm
protein
liu
matsuura
block
activ
disrupt
signal
cascad
anim
model
could
inhibit
matrix
product
prevent
fibrot
process
liu
et
al
rube
et
al
willi
et
al
also
promot
lung
fibrosi
induct
myofibroblast
expans
mention
myofibroblast
key
effector
cell
lung
fibrogenesi
myofibroblast
local
fibrot
foci
site
activ
fibrosi
contribut
ecm
product
directli
promot
resid
lung
fibroblast
differenti
myofibroblast
furthermor
induc
epitheli
cell
undergo
transit
form
fibroblast
henc
myofibroblast
process
term
transit
emt
derynck
akhurst
shown
alveolar
epitheli
cell
undergo
emt
respons
vitro
anim
model
kim
et
al
willi
et
al
biopsi
sampl
epitheli
mesenchym
marker
found
coexpress
cell
suggest
exist
emt
state
fibrot
lung
burkett
et
al
kim
et
al
willi
et
al
wu
et
al
thu
induc
lung
fibrosi
multipl
mechan
consist
promot
effect
tissu
fibrosi
viral
infect
hiv
hcv
hbv
infect
report
upregul
express
variou
tissu
lin
et
al
ray
et
al
case
sarscov
infect
serum
level
elev
earli
phase
sar
pang
et
al
high
level
also
observ
sarscovinfect
lung
cell
includ
alveolar
epitheli
cell
bronchial
epitheli
cell
monocytesmacrophag
uninfect
lung
cell
baa
et
al
et
al
virusinduc
high
level
serum
situ
ligand
lead
hyperactiv
pathway
thu
promot
lung
fibrosi
howev
mechan
sarscov
infect
modul
tissu
level
unknown
importantli
sarscov
modul
express
also
directli
regul
signal
transduct
process
pathway
viral
nucleocapsid
n
protein
sarscov
n
protein
kda
viral
rnabind
protein
share
littl
homolog
counterpart
known
coronavirus
et
al
recent
studi
demonstr
n
protein
associ
interfer
format
complex
zhao
et
al
howev
n
protein
effect
either
phosphoryl
nuclear
accumul
furthermor
could
promot
interact
transcript
coactiv
activ
downstream
gene
lung
epitheli
fibroblast
cell
overexpress
n
protein
enhanc
express
collagen
enhanc
independ
interestingli
n
protein
attenu
apoptosi
agreement
fact
n
protein
found
apoptot
cell
zhao
et
al
thu
sarscov
promot
lung
fibrosi
process
n
protein
ii
system
import
regul
blood
pressur
homeostasi
angiotensinconvert
enzym
ace
play
key
role
gener
angiotensin
ii
angii
angi
biolog
function
recent
identifi
homologu
ace
decreas
angii
level
cleav
angii
therefor
play
opposit
role
ace
angii
gener
respiratori
tract
express
surfac
tracheobronchi
alveolar
epithelium
kuba
et
al
report
protect
role
lung
fibrosi
lung
biopsi
specimen
patient
lung
fibrosi
mrna
enzym
activ
decreas
p
p
respect
li
et
al
mous
model
bleomycininduc
lung
fibrosi
intratrach
administr
small
interf
rna
increas
accumul
lung
collagen
recombin
human
decreas
accumul
lung
collagen
imai
et
al
kuba
et
al
suggest
protect
lung
fibrosi
neg
regul
local
angii
level
addit
role
vasoconstrict
regul
angii
also
contribut
mani
fibrot
diseas
includ
lung
renal
hepat
cardiac
fibrosi
watanab
et
al
angii
mainli
produc
fibroblast
well
activ
macrophag
angii
signal
via
two
receptor
angii
could
stimul
product
secret
cytokin
lung
tissu
process
may
mediat
molteni
et
al
also
regul
level
angii
believ
autocrin
loop
angii
exist
lung
tissu
therefor
ace
inhibitor
agtr
antagonist
block
lung
fibrosi
experiment
anim
uhal
et
al
mous
model
bleomycininduc
lung
fibrosi
antagonist
angiotensin
ii
receptor
reduc
lung
fibrosi
score
effect
accompani
reduct
level
otsuka
et
al
waseda
et
al
addit
regul
ligand
level
angii
also
increas
intracellular
protein
level
facilit
nuclear
transloc
phosphoryl
hao
et
al
recent
report
angii
activ
smad
signal
mapkdepend
manner
su
et
al
angii
also
induc
emt
process
effect
block
antagonist
rodriguezvita
et
al
altogeth
angii
enhanc
signal
interplay
angii
may
promot
lung
fibrosi
addit
enhanc
express
angii
report
upregul
connect
tissu
growth
factor
ctgf
rodriguezvita
et
al
ctgf
may
promot
deposit
ecm
lung
fibrosi
via
mekerk
pathway
pontico
et
al
angii
also
directli
upregul
level
key
protein
pathogenesi
lung
fibrosi
molteni
et
al
well
product
ecm
rodriguezvita
et
al
sever
studi
verifi
essenti
receptor
sarscov
infect
spike
protein
sarscov
could
bind
cell
surfac
bind
promot
viral
entri
cell
induc
fusion
multinucl
cell
syncytia
format
li
et
al
protein
express
alveolar
epitheli
cell
primari
target
sarscov
lung
thu
contribut
sar
diseas
protector
lung
fibrosi
cellular
receptor
viral
infect
imai
et
al
interestingli
sarscov
infect
spike
protein
sarscov
reduc
express
level
viral
infect
kuba
et
al
discuss
decreas
express
result
increas
angii
level
lead
lung
fibrosi
lung
failur
accordingli
invivo
administr
spike
protein
affect
sever
lung
failur
knockout
mice
kuba
et
al
furthermor
administr
spike
protein
mice
led
signific
increas
angii
level
lung
tissu
inhibit
angii
receptor
rescu
effect
spike
protein
imai
et
al
kuba
et
al
altogeth
infect
sarscov
result
downregul
bind
sarscov
spike
protein
spike
proteinmedi
downregul
respons
pathogenesi
lung
fibrosi
upregul
angii
activ
signal
besid
mechan
may
contribut
sarscovmedi
lung
fibrosi
chemokin
promot
lung
fibrosi
patient
lung
fibrosi
level
usual
upregul
emad
emad
wynn
sarscov
infect
upregul
level
patient
elev
level
happen
least
week
diseas
onset
corticosteroid
treatment
reduc
concentr
day
treatment
wong
et
al
mapk
signal
transduc
respond
extracellular
stimul
includ
viral
infect
turn
regul
cell
differenti
ecm
product
hyperactiv
detect
patient
lung
fibrosi
phosphoryl
respons
pulmonari
myofibroblast
activ
express
hu
et
al
yoshida
et
al
sarscov
infect
report
induc
phosphoryl
lung
epitheli
cell
lead
actin
reorgan
mizutani
et
al
surjit
et
al
thu
may
involv
sarscovmedi
lung
fibrosi
fibrosi
usual
bring
irrevers
damag
lung
lung
fibrosi
wide
observ
patient
die
sar
howev
mechan
sarscov
infect
lead
lung
fibrosi
remain
poorli
understood
discuss
two
import
mechan
sarsmedi
fibrosi
activ
signal
degrad
fig
major
challeng
use
learn
prevent
sarscovevok
lung
fibrosi
